Ziemer takes Amadeus back from AMO

Article

The Ziemer group is to assume all worldwide marketing, sales and support duties for AMO's Amadeus II automated microkeratome.

The Ziemer group is to assume all worldwide marketing, sales and support duties for AMO's Amadeus II automated microkeratome.

The Amadeus product line was originally developed by a subsidiary of Ziemer and the rights were sold to AMO in 1999. Ziemer has since developed a global marketing and distribution network that it can rely on to market the Amadeus.

Ziemer also sells the Femto LDV femtosecond laser, making it the only ophthalmic company to offer a choice of microkeratome or femstosecond lasers for corneal refractive surgery.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
Mario Romano, MD, PhD, stresses the importance of thermodynamic control in vitrectomy during the 2025 European Society of Retina Specialists meeting. Photo shows Prof Romano on-camera at the Ophthalmology Times Europe and Modern Retina booth during EURETINA.
© 2025 MJH Life Sciences

All rights reserved.